https://www.thebodypro.com/article/a-better-second-chance-a-top-hiv-clinical-developm
Dolutegravir (Tivicay)

A Better Second Chance: A Top HIV Clinical Development of 2017

    David Alain Wohl, M.D.

    David Alain Wohl, M.D.

    David Alain Wohl, M.D., is a professor at the University of North Carolina, site leader of the UNC AIDS Clinical Trials Unit at Chapel Hill, director of the North Carolina AETC, and co-director of HIV services for the NC state prison system.